Live Breaking News & Updates on Vectura group plc

Stay updated with breaking news from Vectura group plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Head to Head Contrast: Verona Pharma (NASDAQ:VRNA) and Vectura Group (OTCMKTS:VEGPF)

Vectura Group (OTCMKTS:VEGPF – Get Free Report) and Verona Pharma (NASDAQ:VRNA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends. Risk & Volatility Vectura Group has a […] ....

United-states , United-kingdom , Switzerland , Chippenham , Wiltshire , Germany , France , London , City-of , America , David-anthony-gough , Verona-pharma

2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

/PRNewswire/ The "Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update". ....

Monash , South-australia , Australia , Dublin , Ireland , Cambridge , Cambridgeshire , United-kingdom , Japan , Sydney , New-south-wales , Nippon

Big Tobacco faces £25 billion reality check

Big Tobacco anticipates a £25 billion ($31.5 billion) charge, acknowledging a grim future for traditional cigarette brands. ....

Sweden , United-states , Newport , United-kingdom , American , Swedish , Andrea-felsted , Duncan-fox , Philip-morris , Altria-group-inc , Juul-labs-inc , Philip-morris-international-inc

Asthma and COPD Drugs Market was worth $32.99 billion in 2020 and is on track to reach $52.05 billio

The Asthma and COPD Drugs Market has been a key player in the global pharmaceutical industry for years, providing much-needed relief to millions of individuals who suffer from chronic respiratory diseases. These two prevalent conditions, asthma and chronic obstructive pulmonary disease (COPD), have spurred innovatio. ....

Boehringer-ingelheim-international-gmb , Teva-pharmaceutical-industries-ltd , Vectura-group-plc , Roche-ltd , Glaxosmithkline-plc , Astrazeneca-plc , Abbott-laboratories , Acting-beta-agonists , More-insight ,

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Projected to Reach $6.17 Billion by 2030: Increasing Prevalence Drives Growth

/PRNewswire/ The "Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added. ....

Dublin , Ireland , United-states , South-korea , Australia , Turkey , Saudi-arabia , Netherlands , United-arab-emirates , Canada , Russia , Argentina